Table 1 Demographic and clinical characteristics of the study cohort.

From: Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease

Demographic

Number of patients (%)

Male sex (%)

81 (51.6%)

Age, mean (± SD) years

47.61 (± 14.7)

Etiology of liver disease

NAFLD

53 (33.8%)

Viral Hepatitis

42 (26.8%)

Cholestatic liver disease

15 (9.6%)

Autoimmune Hepatitis

9 (5.7%)

Other diagnoses (including NYD)

32 (20.4%)

Normal liver biopsies

6 (3.8%)

Liver fibrosis stage histology

F0

27 (17.2%)

F1

20 (12.7%)

F2

15 (9.6%)

F3

28 (17.8%)

F4

67 (42.7%)

VCTE

Mean LSM (± SD) kPa

15.47 (± 14.51)

 ≥ 9.6 kPa

82 (52.2%)

 > 10.2 kPa

75 (47.8%)

Ultrasound parameters

Liver surface nodularity

46 (29.3%)

Lobar redistribution

38 (24.5%)

Hepatic vein nodularity

28 (18.1%)

  1. kPa, kilo pascal; LSM, liver stiffness measurement; NAFLD, non-alcoholic fatty liver disease; NYD, not yet determined; SD, standard deviation; VCTE, vibration controlled transient elastography.